MATRIX SERVICE CO (MTRX)

US5768531056 - Common Stock

12.91  +0.61 (+4.96%)

Premarket: 13.69 +0.78 (+6.04%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MTRX. MTRX was compared to 45 industry peers in the Construction & Engineering industry. The financial health of MTRX is average, but there are quite some concerns on its profitability. MTRX has a valuation in line with the averages, but on the other hand it scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year MTRX has reported negative net income.
In the past year MTRX had a positive cash flow from operations.
MTRX had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MTRX reported negative operating cash flow in multiple years.

1.2 Ratios

MTRX has a worse Return On Assets (-6.60%) than 86.05% of its industry peers.
With a Return On Equity value of -19.83%, MTRX is not doing good in the industry: 81.40% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.6%
ROE -19.83%
ROIC N/A
ROA(3y)-11.04%
ROA(5y)-9.24%
ROE(3y)-24.05%
ROE(5y)-18.76%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of MTRX (5.23%) is worse than 83.72% of its industry peers.
In the last couple of years the Gross Margin of MTRX has declined.
The Profit Margin and Operating Margin are not available for MTRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.5%
GM growth 5Y-9.82%

5

2. Health

2.1 Basic Checks

MTRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
MTRX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MTRX has more shares outstanding
There is no outstanding debt for MTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

MTRX has an Altman-Z score of 2.03. This is not the best score and indicates that MTRX is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.03, MTRX is doing worse than 62.79% of the companies in the same industry.
There is no outstanding debt for MTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.03
ROIC/WACCN/A
WACC12.98%

2.3 Liquidity

A Current Ratio of 1.06 indicates that MTRX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.06, MTRX is not doing good in the industry: 76.74% of the companies in the same industry are doing better.
MTRX has a Quick Ratio of 1.03. This is a normal value and indicates that MTRX is financially healthy and should not expect problems in meeting its short term obligations.
MTRX's Quick ratio of 1.03 is on the low side compared to the rest of the industry. MTRX is outperformed by 74.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.03

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.00% over the past year.
The Revenue for MTRX has decreased by -11.24% in the past year. This is quite bad
MTRX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.46% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.14%
Revenue 1Y (TTM)-11.24%
Revenue growth 3Y2.64%
Revenue growth 5Y-12.46%
Sales Q2Q%-16.23%

3.2 Future

The Earnings Per Share is expected to grow by 73.14% on average over the next years. This is a very strong growth
MTRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.50% yearly.
EPS Next Y96.73%
EPS Next 2Y73.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year23.33%
Revenue Next 2Y18.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

MTRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
MTRX is valuated correctly with a Price/Forward Earnings ratio of 12.21.
MTRX's Price/Forward Earnings ratio is rather cheap when compared to the industry. MTRX is cheaper than 95.35% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.53, MTRX is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 12.21

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MTRX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.39
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MTRX's earnings are expected to grow with 73.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.14%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MTRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MATRIX SERVICE CO

NASDAQ:MTRX (1/14/2025, 8:00:01 PM)

Premarket: 13.69 +0.78 (+6.04%)

12.91

+0.61 (+4.96%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners84.93%
Inst Owner Change0%
Ins Owners4.12%
Ins Owner Change7.96%
Market Cap355.67M
Analysts82.86
Price Target18.36 (42.22%)
Short Float %1.42%
Short Ratio2.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.61%
Min EPS beat(2)-1.42%
Max EPS beat(2)34.64%
EPS beat(4)1
Avg EPS beat(4)-87.7%
Min EPS beat(4)-307.54%
Max EPS beat(4)34.64%
EPS beat(8)2
Avg EPS beat(8)-112.3%
EPS beat(12)3
Avg EPS beat(12)-95.75%
EPS beat(16)3
Avg EPS beat(16)-358.91%
Revenue beat(2)0
Avg Revenue beat(2)-6.31%
Min Revenue beat(2)-8.39%
Max Revenue beat(2)-4.23%
Revenue beat(4)0
Avg Revenue beat(4)-10.88%
Min Revenue beat(4)-16.66%
Max Revenue beat(4)-4.23%
Revenue beat(8)0
Avg Revenue beat(8)-7.81%
Revenue beat(12)3
Avg Revenue beat(12)-4.96%
Revenue beat(16)3
Avg Revenue beat(16)-6.77%
PT rev (1m)0%
PT rev (3m)5.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-287.08%
EPS NY rev (1m)0%
EPS NY rev (3m)-118.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.21
P/S 0.51
P/FCF 3.39
P/OCF 3.14
P/B 2.27
P/tB 2.82
EV/EBITDA N/A
EPS(TTM)-1.18
EYN/A
EPS(NY)1.06
Fwd EY8.19%
FCF(TTM)3.81
FCFY29.5%
OCF(TTM)4.12
OCFY31.87%
SpS25.27
BVpS5.68
TBVpS4.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.6%
ROE -19.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.23%
FCFM 15.07%
ROA(3y)-11.04%
ROA(5y)-9.24%
ROE(3y)-24.05%
ROE(5y)-18.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.5%
GM growth 5Y-9.82%
F-Score6
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 79.58%
Cap/Sales 1.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 1.03
Altman-Z 2.03
F-Score6
WACC12.98%
ROIC/WACCN/A
Cap/Depr(3y)50.41%
Cap/Depr(5y)54.51%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.14%
EPS Next Y96.73%
EPS Next 2Y73.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.24%
Revenue growth 3Y2.64%
Revenue growth 5Y-12.46%
Sales Q2Q%-16.23%
Revenue Next Year23.33%
Revenue Next 2Y18.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year130.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y239.9%
FCF growth 3YN/A
FCF growth 5Y24.61%
OCF growth 1Y261.31%
OCF growth 3YN/A
OCF growth 5Y11.89%